Results
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
|
|
|
32.
|
|
|
|
33.
|
|
|
|
34.
|
|
|
|
35.
|
|
|
|
36.
|
Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection. [electronic resource] by
- Zaak, D
- Frimberger, D
- Stepp, H
- Wagner, S
- Baumgartner, R
- Schneede, P
- Siebels, M
- Knüchel, R
- Kriegmair, M
- Hofstetter, A
Producer: 20011101
In:
The Journal of urology vol. 166
Availability: No items available.
|
|
|
37.
|
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients. [electronic resource] by
- Siebels, M
- Rohrmann, K
- Oberneder, R
- Stahler, M
- Haseke, N
- Beck, J
- Hofmann, R
- Kindler, M
- Kloepfer, P
- Stief, C
Producer: 20110524
In:
World journal of urology vol. 29
Availability: No items available.
|
|
|
38.
|
Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma. [electronic resource] by
- Motzer, R J
- Rakhit, A
- Thompson, J
- Gurney, H
- Selby, P
- Figlin, R
- Negrier, S
- Ernst, S
- Siebels, M
- Ginsberg, M
- Rittweger, K
- Hooftman, L
Producer: 20030320
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 13
Availability: No items available.
|
|
|
39.
|
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). [electronic resource] by
- Atzpodien, J
- Kirchner, H
- Rebmann, U
- Soder, M
- Gertenbach, U
- Siebels, M
- Roigas, J
- Raschke, R
- Salm, S
- Schwindl, B
- Müller, S C
- Hauser, S
- Leiber, C
- Huland, E
- Heinzer, H
- Siemer, S
- Metzner, B
- Heynemann, H
- Fornara, P
- Reitz, M
Producer: 20060915
In:
British journal of cancer vol. 95
Availability: No items available.
|
|
|
40.
|
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). [electronic resource] by
- Atzpodien, J
- Kirchner, H
- Jonas, U
- Bergmann, L
- Schott, H
- Heynemann, H
- Fornara, P
- Loening, S A
- Roigas, J
- Müller, S C
- Bodenstein, H
- Pomer, S
- Metzner, B
- Rebmann, U
- Oberneder, R
- Siebels, M
- Wandert, T
- Puchberger, T
- Reitz, M
Producer: 20040420
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 22
Availability: No items available.
|